Sudden Complete Versus Gradual Weaning from Nasal Continuous Positive Airway Pressure in Preterm Neonates: A Randomized Controlled Trial

Document Type : Original Article


1 Department of Pediatrics, Isfahan University of Medical Sciences, Isfahan, Iran

2 Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran

3 Tehran University of Medical Sciences, Tehran, Iran


Background: Continuous positive airway pressure (CPAP) is used as respiratory support in preterm neonates; however, the best weaning method has not yet been determined. In this study, we compared sudden complete and gradual weaning from nasal CPAP (NCPAP) in preterm newborns.
Methods: This randomized controlled trial was conducted on 62 preterm neonates who were born with a gestational week of < 32 weeks and required NCPAP for at least 24 h. The neonates were stable on NCPAP at 0.21 FiO2 and 5 cm H2O positive end-expiratory pressure. They were randomized into two groups of gradual and sudden weaning using random numbers sheet. The primary outcome was successful weaning at the first attempt. The secondary outcomes included the number of NCPAP weaning attempts, the need for mechanical ventilation (nasal and endotracheal), duration of NCPAP, oxygenation, and length of hospital stay.
Results: According to the results, 80.6% of the patients in the sudden weaning group and 74.2% of the patients in the gradual weaning group were weaned successfully in the first attempt. However, there was no statistically significant difference between the two groups in this regard (P=0.54). Duration of NCPAP was significantly lower in the sudden weaning group, compared to that in the gradual weaning group (P<0.001). Numbers of NCPAP weaning attempts, the need for mechanical ventilation, duration of oxygenation, and hospital stay in the two groups were not significantly different.
Conclusion: There was no difference between sudden complete and gradual weaning from NCPAP in terms of treatment success and complications. The selection of the appropriate technique may depend on available equipment and treatment costs.


1. De Paoli AG, Morley C, Davis PG. Nasal NCPAP for neonates: what do we know in 2003? Arch Dis Child Fetal Neonatal Ed. 2003; 88(3):F168-72.
 2. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, et al. Nasal NCPAP or intubation at birth for very preterm infants. N Engl J Med. 2008; 358(7):700-8.
3. Aly H. Ventilation without tracheal intubation. Pediatrics. 2009; 124(2):786-9.
4. Dunn MS, Kaempf J, de Klerk A, de Klerk R, Reilly M, Howard D, et al. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics. 2011; 128(5): e1069-76.
5. Schmolzer GM, Kumar M, Pichler G, Aziz K, O’Reilly M, Cheung PY. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ. 2013; 347:f5980.
6. Perez LA, Gonzalez DM, Alvarez KM, Diaz-Martinez LA. Nasal CPAP versus mechanical ventilation in 28 to 32-week preterm infants with early surfactant administration. Biomedica. 2014; 34(4):612-23.
 7. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev. 2003; 2:CD000143.
 8. De Paoli AG, Davis P, Lemyre B. Nasal continuous positive airway pressure versus nasal intermittent positive pressure ventilation for preterm neonates: a systematic review and meta‐analysis. Acta Paediatr. 2003; 92(1):70-5.
9. Levene MI, Fawer CL, Lamont RF. Risk factors in the development of intraventricular haemorrhage in the preterm neonate. Arch Dis Child. 1982; 57(6):410-7.
10. Friedman CA, Menchaca RC, Baker MC, Rivas CK, Laberge RN, Rios EH, et al. Bubble nasal CPAP, early surfactant treatment, and rapid extubation are associated with decreased incidence of bronchopulmonary dysplasia in very-low-birthweight newborns: efficacy and safety considerations. Respir Care. 2013; 58(7):1134-42.
11. Dunn MS, Reilly MC. Approaches to the initial respiratory management of preterm neonates. Paediatr Respir Rev. 2003; 4(1):2-8.
12. Jardine L, Davies MW. Withdrawal of neonatal continuous positive airway pressure: current practice in Australia. Pediatr Int. 2008; 50(4):572-5.
13. Amatya S, Rastogi D, Bhutada A, Rastogi S. Weaning of nasal CPAP in preterm infants: who, when and how? A systematic review of the literature. World J Pediatr. 2015; 11(1):7-13.
 14. Rastogi S, Rajasekhar H, Gupta A, Bhutada A, Rastogi D, Wung JT. Factors affecting the weaning from nasal CPAP in preterm neonates. Int J Pediatr. 2012; 2012:416073.
 15. Abdel-Hady H, Shouman B, Nasef N. Weaning preterm infants from continuous positive airway pressure: evidence for best practice. World J Pediatr. 2015; 11(3):212-8.
 16. Amatya S, Macomber M, Bhutada A, Rastogi D, Rastogi S. Sudden versus gradual pressure wean from Nasal CPAP in preterm infants: a randomized controlled trial. J Perinatol. 2017; 37(6):662-7.
 17. Rastogi S, Wong W, Gupta A, Bhutada A, Deepa R, Maimonides Neonatal G. Gradual versus sudden weaning from nasal CPAP in preterm infants: a pilot randomized controlled trial. Respir Care. 2013; 58(3):511-6.
18. Todd DA, Wright A, Broom M, Chauhan M, Meskell S, Cameron C, et al. Methods of weaning preterm babies<30 weeks gestation off CPAP: a multicenter randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2012; 97(4):F236-40.
 19. Tang J, Reid S, Lutz T, Malcolm G, Oliver S, Osborn DA. Randomised controlled trial of weaning strategies for preterm infants on nasal continuous positive airway pressure. BMC Pediatr. 2015; 15:147.